Fig. 3From: P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasmsUnivariate survival analyses of prognostic parameters in 163 patients. Median survival in months are shown for each parameter, as well as HRs with CI and p-values. The 95% confidence intervals are shown as horizontal lines. CI’s crossing the line at HR = 1 are non-significant. The dot on each line indicates the HR. NR = not reached. *Indicates significant p-values < 0.05Back to article page